GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
Top Headlines
Archived
•
November 9, 2026
•
2 views
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
Source: CBS News Top | https://www.cbsnews.com/latest/rss/main - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



